Literature DB >> 36124276

Advantages of combined photodynamic therapy in the treatment of oncological diseases.

Mikhail Grin1, Nikita Suvorov1, Petr Ostroverkhov1, Viktor Pogorilyy1, Nikita Kirin1, Alexander Popov1, Anna Sazonova2, Elena Filonenko3.   

Abstract

When conducting combined therapy of malignant neoplasms, treatment methods with various mechanisms of antitumor effects are used, while an additive or even synergistic effect can be realized. Combination treatment regimens are aimed at increasing the efficiency and, above all, at the complete eradication of the tumor, which can be achieved either by suppressing the survival mechanisms in PDT-resistant tumor cells or by pre-attenuation of tumor cells so that they become more susceptible to subsequent PDT. Photodynamic therapy is an approved medical technology for the treatment of various malignant neoplasms, and several precancerous and non-cancer diseases. To date, numerous data have been published on the combined use of PDT with traditional and innovative methods of treatment. This review considers research in this area in recent years. © International Union for Pure and Applied Biophysics (IUPAB) and Springer-Verlag GmbH Germany, part of Springer Nature 2022.

Entities:  

Keywords:  Combined cancer therapy; Nanoparticle drug delivery; Photodynamic therapy; Photosensitizer

Year:  2022        PMID: 36124276      PMCID: PMC9481804          DOI: 10.1007/s12551-022-00962-6

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  114 in total

1.  Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug.

Authors:  Abugafar M L Hossion; Moses Bio; Gregory Nkepang; Samuel G Awuah; Youngjae You
Journal:  ACS Med Chem Lett       Date:  2012-11-21       Impact factor: 4.345

2.  Photobiological properties of phthalocyanine photosensitizers Photosens, Holosens and Phthalosens: A comparative in vitro analysis.

Authors:  Anna A Brilkina; Lubov V Dubasova; Ekaterina A Sergeeva; Anton J Pospelov; Natalia Y Shilyagina; Natalia M Shakhova; Irina V Balalaeva
Journal:  J Photochem Photobiol B       Date:  2018-12-27       Impact factor: 6.252

3.  Efficient activation of a visible light-activatable CA4 prodrug through intermolecular photo-unclick chemistry in mitochondria.

Authors:  Moses Bio; Pallavi Rajaputra; Irene Lim; Pritam Thapa; Bomaonye Tienabeso; Robert E Hurst; Youngjae You
Journal:  Chem Commun (Camb)       Date:  2017-01-23       Impact factor: 6.222

Review 4.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

5.  Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.

Authors:  Pritam Thapa; Mengjie Li; Moses Bio; Pallavi Rajaputra; Gregory Nkepang; Yajing Sun; Sukyung Woo; Youngjae You
Journal:  J Med Chem       Date:  2016-03-22       Impact factor: 7.446

Review 6.  Photodynamic therapy (PDT) of cancer: from local to systemic treatment.

Authors:  Janusz M Dąbrowski; Luis G Arnaut
Journal:  Photochem Photobiol Sci       Date:  2015-10       Impact factor: 3.982

7.  Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer.

Authors:  S Imamura; Y Kusunoki; N Takifuji; S Kudo; K Matsui; N Masuda; M Takada; S Negoro; S Ryu; M Fukuoka
Journal:  Cancer       Date:  1994-03-15       Impact factor: 6.860

8.  Controlled drug delivery vehicles for cancer treatment and their performance.

Authors:  Sudipta Senapati; Arun Kumar Mahanta; Sunil Kumar; Pralay Maiti
Journal:  Signal Transduct Target Ther       Date:  2018-03-16

9.  Clinical efficacy of Mohs surgery combined with topical photodynamic therapy for facial basal cell carcinoma.

Authors:  Junbo Zhang; Yuangang Lu; Xingcun Zhang; Yunchuan Yang; Huiling Kou; Yuanyuan Wang
Journal:  J Cancer Res Ther       Date:  2020-09       Impact factor: 1.805

Review 10.  Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications.

Authors:  Lei Duan; Li Yang; Juan Jin; Fang Yang; Dong Liu; Ke Hu; Qinxin Wang; Yuanbin Yue; Ning Gu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.